Spire Healthcare Group (LON:SPI – Get Free Report) released its quarterly earnings results on Wednesday. The company reported GBX (0.50) EPS for the quarter, Digital Look Earnings reports. Spire Healthcare Group had a net margin of 1.04% and a return on equity of 2.22%.
Spire Healthcare Group Trading Up 0.4%
Shares of SPI traded up GBX 1 on Thursday, reaching GBX 247.50. 71,514,227 shares of the company’s stock were exchanged, compared to its average volume of 5,796,127. Spire Healthcare Group has a 12 month low of GBX 140.80 and a 12 month high of GBX 249. The stock has a market capitalization of £991.48 million, a P/E ratio of 61.88, a price-to-earnings-growth ratio of 1.06 and a beta of 0.93. The company has a current ratio of 0.63, a quick ratio of 0.73 and a debt-to-equity ratio of 177.14. The business has a 50 day moving average price of GBX 238.06 and a two-hundred day moving average price of GBX 207.59.
Wall Street Analyst Weigh In
Separately, Royal Bank Of Canada downgraded Spire Healthcare Group to a “sector perform” rating and reduced their price objective for the stock from GBX 300 to GBX 250 in a report on Monday, September 7th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 247.50.
About Spire Healthcare Group
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments.
Further Reading
- Five stocks we like better than Spire Healthcare Group
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Apple’s $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Spire Healthcare Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group and related companies with MarketBeat.com's FREE daily email newsletter.
